The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies, as well as government agencies, to partner at unprecedented speed to develop vaccines, treatments, and tests This article covers the last four months of deal data provided by Chris Dokomajilar of DealForma Our team at PharmaShots […]Read More
